Hepatic lymphatics in alcohol-associated liver disease
酒精相关性肝病中的肝淋巴管
基本信息
- 批准号:10824029
- 负责人:
- 金额:$ 21.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-18 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAlcohol abuseAlcohol consumptionAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsAntigen-Presenting CellsAntigensCaliforniaCell physiologyCell surfaceCholestasisChronicCirrhosisClinicalCollaborationsConsumptionDevelopmentDietEncapsulatedEndothelial CellsEthanolExhibitsExtravasationFoundationsFutureGene ExpressionGoalsHepaticHepatocyteHybridsIL7 geneImpairmentInflammationInflammation MediatorsInflammatory ResponseInfusion proceduresLiquid substanceLiverLiver diseasesLymphangiogenesisLymphaticLymphatic Endothelial CellsLymphatic SystemLymphatic functionMesothelial CellMessenger RNAModelingMolecularMusPathologicPatientsPennsylvaniaPhenotypePopulationPrognosisProtocols documentationRegulationReporterRoleStructureTechnologyTestingTissuesUniversitiesVascular Endothelial Growth Factor Calcohol effectcholangiocytechronic alcohol ingestionclinically relevantexperimental studyfeedinggain of functionin vivolipid nanoparticleliver inflammationliver injuryloss of functionlymph nodeslymphatic drainagelymphatic dysfunctionlymphatic vesselnovelnovel therapeutic interventionoverexpressionpatient subsetssingle-cell RNA sequencingtranscriptomicswestern diet
项目摘要
SUMMARY
A subset of patients with alcohol-associated liver disease (ALD) develop severe alcoholic hepatitis
(AH), carrying a very poor prognosis. Control of inflammation is a key to the treatment of AH. Hepatic
lymphatics are highly involved in the regulation of the inflammatory response by discharging extravasated
fluids, inflammatory mediators, antigens, and antigen-presenting cells to lymph nodes outside the liver.
However, how the hepatic lymphatic system is involved in the development of ALD remains largely unknown.
The goal of this exploratory study is to advance our understanding of hepatic lymphatics in the progression of
AH and explore whether increasing lymphatic vessels (LVs) and lymphatic drainage can be a novel therapeutic
strategy for AH.
Given that lymphatics generally help to reduce tissue inflammation, we hypothesize that chronic
alcohol consumption may impair hepatic lymphatic endothelial cell (EC) function and lymphatic drainage,
facilitating the progression to AH. Contrarily, enhancing lymphangiogenesis (new LV formation) via
overexpression of vascular endothelial growth factor (VEGF)-C, the most potent lymphangiogenic factor, may
ameliorate AH. To test these hypotheses, we propose the following two Aims:
Aim 1. Determine the role of the hepatic lymphatic system in AH.
Aim 2. Explore the potential of the VEGF-C mRNA LNP (lipid nanoparticle) technology for the treatment of
severe AH.
This study will explore an important, but poorly understood subject, liver lymphatics in ALD, addressing
the effect of alcohol on hepatic lymphatic functions and its implications in the development of AH. Results from
the two Aims above will provide the foundation for many future studies to advance our understanding of the
lymphatic system in liver disease in general and AH in particular, including a study addressing the molecular
mechanism of lymphatic impairment by alcohol as well as a study aiming at clinical use of VEGF-C mRNA-LNP
for the treatment of AH.
总结
酒精相关性肝病(ALD)患者的一个子集发展为重度酒精性肝炎
(AH)预后很差。控制炎症是治疗AH的关键。肝
抗炎药高度参与炎症反应的调节,
液体、炎症介质、抗原和抗原呈递细胞转移到肝外的淋巴结。
然而,肝淋巴系统如何参与ALD的发展仍然是未知的。
这项探索性研究的目的是提高我们对肝硬化进展中肝硬化的认识。
AH并探讨增加淋巴管(LV)和淋巴引流是否可以成为一种新的治疗方法
战略为。
考虑到抗炎药通常有助于减少组织炎症,我们假设慢性炎症是由炎症引起的。
饮酒可能损害肝淋巴管内皮细胞(EC)功能和淋巴引流,
促进向AH的发展。间接地,增强淋巴管生成(新的LV形成),通过
血管内皮生长因子(VEGF)-C是最有效的淋巴管生成因子,
改善AH。为了验证这些假设,我们提出以下两个目标:
目标1。确定肝淋巴系统在AH中的作用。
目标二。探索VEGF-C mRNA LNP(脂质纳米粒)技术治疗
严重啊。
这项研究将探讨一个重要的,但了解不多的主题,ALD的肝脏代谢,解决
酒精对肝淋巴功能的影响及其在AH发生中的意义。结果
上述两个目标将为未来的许多研究提供基础,以促进我们对
淋巴系统在肝脏疾病中的作用,特别是AH,包括一项研究,
酒精引起的淋巴损伤机制以及针对VEGF-C mRNA-LNP临床应用的研究
治疗AH。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YASUKO IWAKIRI其他文献
YASUKO IWAKIRI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YASUKO IWAKIRI', 18)}}的其他基金
Endotheliopathy and liver injury in COVID-19
COVID-19 中的内皮病和肝损伤
- 批准号:
10468220 - 财政年份:2021
- 资助金额:
$ 21.16万 - 项目类别:
Endotheliopathy and liver injury in COVID-19
COVID-19 中的内皮病和肝损伤
- 批准号:
10662455 - 财政年份:2021
- 资助金额:
$ 21.16万 - 项目类别:
Endotheliopathy and liver injury in COVID-19
COVID-19 中的内皮病和肝损伤
- 批准号:
10319358 - 财政年份:2021
- 资助金额:
$ 21.16万 - 项目类别:
The role of Kupffer cells in alcohol-induced liver disease
库普弗细胞在酒精性肝病中的作用
- 批准号:
9761401 - 财政年份:2017
- 资助金额:
$ 21.16万 - 项目类别:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
酒精性肝性骨营养不良的机制
- 批准号:
8969937 - 财政年份:2016
- 资助金额:
$ 21.16万 - 项目类别:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
酒精性肝性骨营养不良的机制
- 批准号:
9326892 - 财政年份:2016
- 资助金额:
$ 21.16万 - 项目类别:
相似海外基金
A novel animal model to study the association between alcohol abuse during late adolescence with common conditions observed in combat Veterans
一种新的动物模型,用于研究青春期后期酗酒与退伍军人中观察到的常见状况之间的关联
- 批准号:
10644999 - 财政年份:2022
- 资助金额:
$ 21.16万 - 项目类别:
Reinforcement as a Prospective Predictor of Real-time Alcohol Abuse Following Bariatric Surgery
强化作为减肥手术后实时酒精滥用的前瞻性预测因子
- 批准号:
10370120 - 财政年份:2022
- 资助金额:
$ 21.16万 - 项目类别:
A novel animal model to study the association between alcohol abuse during late adolescence with common conditions observed in combat Veterans
一种新的动物模型,用于研究青春期后期酗酒与退伍军人中观察到的常见状况之间的关联
- 批准号:
10368295 - 财政年份:2022
- 资助金额:
$ 21.16万 - 项目类别:
Reinforcement as a Prospective Predictor of Real-time Alcohol Abuse Following Bariatric Surgery
强化作为减肥手术后实时酒精滥用的前瞻性预测因子
- 批准号:
10705563 - 财政年份:2022
- 资助金额:
$ 21.16万 - 项目类别:
The Functional Implications of Astrocytic GPCR-signaling on Alcohol Abuse
星形胶质细胞 GPCR 信号传导对酒精滥用的功能影响
- 批准号:
10472456 - 财政年份:2021
- 资助金额:
$ 21.16万 - 项目类别:
Trauma and Neurobiological Threat Reactivity as Risk Factors for Alcohol Abuse in Youth
创伤和神经生物学威胁反应作为青少年酗酒的危险因素
- 批准号:
10582520 - 财政年份:2021
- 资助金额:
$ 21.16万 - 项目类别:
Trauma and Neurobiological Threat Reactivity as Risk Factors for Alcohol Abuse in Youth
创伤和神经生物学威胁反应作为青少年酗酒的危险因素
- 批准号:
10368089 - 财政年份:2021
- 资助金额:
$ 21.16万 - 项目类别:
The Functional Implications of Astrocytic GPCR-signaling on Alcohol Abuse
星形胶质细胞 GPCR 信号传导对酒精滥用的功能影响
- 批准号:
10089613 - 财政年份:2021
- 资助金额:
$ 21.16万 - 项目类别: